Diabetes News and Research

Latest Diabetes News and Research

Develogen enters license, collaboration agreement with MedImmune on insulin beta cell regeneration

Evotec AG today announced that via its subsidiary Develogen AG it has entered into a license and collaboration agreement with MedImmune (the global biologics unit of AstraZeneca), in the diabetes therapeutic area, with a particular focus on the regeneration of insulin producing beta cells. The license gives MedImmune exclusive access to a portfolio of research programs and represents the first deal executed by Evotec on beta cell regeneration assets and capabilities.

15 Dec 2010

Research reveals pattern of declining health among Mexican-American immigrants

Mexican-Americans who are most integrated into the culture including those born in the United States, and not recent immigrants appear less healthy and more likely to require resources to manage their health conditions than more recent, less-integrated migrants, according to a new study from Rice University, Duke University and the University of Colorado Denver.

15 Dec 2010

Researchers introduce new class of drugs for HCV patients

To improve the care for individuals infected with the hepatitis C virus, a major health problem and a leading cause of chronic liver disease around the world, nearly 200 international hepatitis experts have taken an important step in escalating the introduction of a new class of targeted therapies for HCV – direct-acting antivirals.

15 Dec 2010

Survey reveals 40% of consumers prefer to purchase vision care services during weekends, evenings

An independent, national survey reveals 40 percent of consumers prefer to shop for and purchase vision correction services during evenings or weekends.

15 Dec 2010

Cell Biosciences receives US Patent for NanoPro assay technology

Cell Biosciences, Inc. today announced the issuance of Patent No. 7,846,676 for "Methods and Devices for Analyte Detection" by the United States Patent and Trademark Office.

15 Dec 2010

HUP launches Penn Hand Transplant Program

The Penn Transplant Institute, the Department of Orthopaedic Surgery and the Division of Plastic Surgery at the Hospital of the University of Pennsylvania (HUP) have collaborated to form the Penn Hand Transplant Program.

15 Dec 2010

New HHS Strategy on Multiple Chronic Conditions

The U.S. Department of Health and Human Services today issued its new Strategic Framework on Multiple Chronic Conditions - an innovative private-public sector collaboration to coordinate responses to a growing challenge.

15 Dec 2010

Tumor suppressor p53 may serve as 'Guardian against Genome Reprogramming'

A close collaboration between researchers at the Salk Institute for Biological Studies and the Institute for Advanced Study found that the tumor suppressor p53, long thought of as the "Guardian of the Genome," may do more than thwart cancer-causing mutations. It may also prevent established cancer cells from sliding toward a more aggressive, stem-like state by serving as a "Guardian against Genome Reprogramming."

15 Dec 2010

BRIC researchers discover new protein that improves immune system

Researchers at BRIC, the University of Copenhagen, have discovered for the first time a protein normally found in the body that can act to prevent chronic tissue inflammation.

15 Dec 2010

Lung protective strategy can increase the number of lungs available for transplant

Simple changes to how ventilators are used could almost double the number of lungs available for transplants, according to new international research involving a doctor at St. Michael's Hospital.

15 Dec 2010

Inhaled corticosteroids may cause diabetes

In a study published in the most recent issue of The American Journal of Medicine, researchers found that inhaled corticosteroids were associated with a 34% increase in the rate of diabetes onset and in the rate of diabetes progression. At the highest inhaled doses the risk increased by 64% in diabetes onset and 54% in diabetes progression.

15 Dec 2010

DARA's KRN5500 reduces allodynia in Phase 2a study for neuropathic pain in cancer patients

DARA BioSciences, Inc. announced today additional positive results from its successfully completed KRN5500 Phase 2a Clinical Study for treatment of neuropathic pain in patients with cancer. Statistically significant primary endpoint results were released earlier.

15 Dec 2010

Study links large waistline to increased risk of heart problems and type 2 diabetes

Researchers at Eastern Virginia Medical School’s Strelitz Diabetes Center and the school’s department of physiological sciences have published research showing a strong link between a large waistline and increased risk of Type 2 diabetes and cardiovascular disease.

14 Dec 2010

Health report card for NSW

The latest report on NSW health shows that it is better than most in heart disease and cancer statistics. However 60% of the state are overweight or obese says the report and 70% of the NSW adults say they have been diagnosed with long-term illnesses.

14 Dec 2010

Tolerx commences TRX518 Phase 1 trial in malignant melanoma

Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.

14 Dec 2010

VIVUS submits briefing document to FDA in effort to secure regulatory approval for QNEXA

VIVUS, Inc. today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010. The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.

14 Dec 2010

Workplace interactions may educate people about organ donation process

Face-to-face workplace interactions may be the best way to educate and encourage people to consider becoming organ donors, according to new research from Purdue University.

14 Dec 2010

Lexicon reports top-line results from LX2931 Phase 2a study in rheumatoid arthritis

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.

14 Dec 2010

Unigene enters agreement with GSK to advance oral PTH Phase 2 program for osteoporosis

Unigene Laboratories, Inc. today announced that the Company entered into an amended and restated exclusive worldwide license agreement with GlaxoSmithKline (GSK) to develop and commercialize an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women and plans to initiate a Phase 2 study in the first quarter of 2011.

14 Dec 2010

UnitedHealthcare's care management solution will improve diabetes prescription drug adherence: Study

HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that UnitedHealthcare's innovative care management solution in the Phoenix market will improve diabetes prescription drug adherence. According to the recent West Health Plan Analysis, the use of non-physician, credentialed providers is intended to create virtual medical homes that allow non-traditional providers, such as pharmacists, wellness coordinators and lifestyle coaches, to recommend and coordinate necessary prescription adjustments.

14 Dec 2010

Diabetes News and Research

Latest Diabetes News and Research

Develogen enters license, collaboration agreement with MedImmune on insulin beta cell regeneration

Research reveals pattern of declining health among Mexican-American immigrants

Researchers introduce new class of drugs for HCV patients

Survey reveals 40% of consumers prefer to purchase vision care services during weekends, evenings

Cell Biosciences receives US Patent for NanoPro assay technology

HUP launches Penn Hand Transplant Program

New HHS Strategy on Multiple Chronic Conditions

Tumor suppressor p53 may serve as 'Guardian against Genome Reprogramming'

BRIC researchers discover new protein that improves immune system

Lung protective strategy can increase the number of lungs available for transplant

Inhaled corticosteroids may cause diabetes

DARA's KRN5500 reduces allodynia in Phase 2a study for neuropathic pain in cancer patients

Study links large waistline to increased risk of heart problems and type 2 diabetes

Health report card for NSW

Tolerx commences TRX518 Phase 1 trial in malignant melanoma

VIVUS submits briefing document to FDA in effort to secure regulatory approval for QNEXA

Workplace interactions may educate people about organ donation process

Lexicon reports top-line results from LX2931 Phase 2a study in rheumatoid arthritis

Unigene enters agreement with GSK to advance oral PTH Phase 2 program for osteoporosis

UnitedHealthcare's care management solution will improve diabetes prescription drug adherence: Study

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Diabetes News and Research

Latest Diabetes News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in